ENB Therapeutics
ENB Therapeutics is developing therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.
Employees
Enterprise value
$10—16m
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.